Lincoln Chee

Lincoln Chee General Information

Biography

Dr. Lincoln Chee serves as Senior Advisor at LionRock Capital. He served as Managing Director at Vertex Ventures HC. He served as Managing Director, Healthcare and LifeScience at Vertex Venture Holdings. He was a Board Member at Earlens. He has over 25 years of experience in healthcare as a surgeon, executive, and investor. Prior to joining Vertex, he served as CEO and Board Member of Quality Healthcare, Hong Kong's first publicly listed healthcare company. He led the growth and eventual buyout by Fortis Group in 2010. In 2009, he was selected as Outstanding Entrepreneur of HK. He also held committee positions with Hong Kong Government Food and Health Bureau on e-health Records and Primary Care Delivery Models and was an advisory member of the Hong Kong Trade and Development Council. Since 2013, he has been an operating partner advisor for Advent International in healthcare. He has also held an ENT Consultant position at Singapore General Hospital. He is currently on the Board of Holaira and Visterra. Notable past investments include Twelve (acquired by Medtronic), Arana Therapeutics (acquired by Cephalon), Biosensors International (IPO), and Phoenix Hospital Group (IPO). Lincoln holds an MBBS from the National University of Singapore. He is a Fellow of the Royal College of Surgeons Edinburgh and a Fellow Academy of Medicine Singapore in Otorhinolaryngology-Head & Neck Surgery. He also served as a Board Member at Sensimed.